(Q46453980)

English

Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate

scientific article published in August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

1 reference

based on heuristic

inferred from title

Maria Trojanowska

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Peter Ten Dijke

object named as

Peter ten Dijke

7

0 references

author name string

Jaspreet Pannu

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Yoshihide Asano

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Sashidhar Nakerakanti

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Edwin Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Stefania Jablonska

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Maria Blaszczyk

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

publication date

1 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

58

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

2528-2537

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FART.23698

21 January 2018

Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FART.23698

21 January 2018

Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FART.23698

21 January 2018

Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin

1 reference

https://api.crossref.org/works/10.1002%2FART.23698

21 January 2018

Identifiers

10.1002/ART.23698

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46453980&oldid=2112436760"